Get started
EXACT SCIENCES CORPEXACT SCIENCES CORPEXACT SCIENCES CORP

EXACT SCIENCES CORP

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Forecast Bonds

1EXAS chart


Full chart

1EXAS upcoming earnings


Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—

Key stats


Market capitalization
‪8.62 B‬ EUR
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−5.085 EUR
Net income (FY)
‪−993.85 M‬ EUR
Revenue (FY)
‪2.67 B‬ EUR
Shares float
‪182.93 M‬
Beta (1Y)
0.28

Employees


Employees (FY)
‪7 K‬
Change (1Y)
+400 +6.06%
Revenue / Employee (1Y)
‪380.72 K‬ EUR
Net income / Employee (1Y)
‪−141.98 K‬ EUR

About Exact Sciences Corporation


Sector
Health Technology
Industry
Medical Specialties
CEO
Kevin T. Conroy
Website
exactsciences.com
Headquarters
Madison
Founded
1995
FIGI
BBG01TNXQFV1
EXACT Sciences Corp. is a cancer screening and diagnostics company. The firm focuses on the early detection and prevention of some forms of cancer. It offers a non-invasive screening test called Cologuard for the early detection of colorectal cancer and pre-cancer and Oncotype DX. The company was founded on February 10, 1995, and is headquartered in Madison, WI.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

1EXAS news



Ideas



See all ideas 

Analyst rating


An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

1EXAS highest yielding bonds


EXAS4806408
Exact Sciences Corporation 0.375% 15-MAR-2027
Yield to maturity
5.19%
Maturity date
Mar 15, 2027
EXAS5793007
Exact Sciences Corporation 1.75% 15-APR-2031
Yield to maturity
3.80%
Maturity date
Apr 15, 2031
EXAS4957195
Exact Sciences Corporation 0.375% 01-MAR-2028
Yield to maturity
3.54%
Maturity date
Mar 1, 2028
EXAS5549793
Exact Sciences Corporation 2.0% 01-MAR-2030
Yield to maturity
2.65%
Maturity date
Mar 1, 2030

See all 1EXAS bonds 

Sparks


Curated watchlists where 1EXAS is featured.

See all sparks 


Check out other big names from the same industry as 1EXAS.

Frequently Asked Questions


The current price of 1EXAS is 45.210 EUR — it has increased by 14.04% in the past 24 hours. Watch EXACT SCIENCES CORP stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on MIL exchange EXACT SCIENCES CORP stocks are traded under the ticker 1EXAS.
1EXAS stock has risen by 14.88% compared to the previous week, the month change is a 14.88% rise, over the last year EXACT SCIENCES CORP has showed a 14.88% increase.
We've gathered analysts' opinions on EXACT SCIENCES CORP future price: according to them, 1EXAS price has a max estimate of 79.74 EUR and a min estimate of 47.84 EUR. Watch 1EXAS chart and read a more detailed EXACT SCIENCES CORP stock forecast: see what analysts think of EXACT SCIENCES CORP and suggest that you do with its stocks.
1EXAS reached its all-time high on May 2, 2025 with the price of 45.210 EUR, and its all-time low was 39.355 EUR and was reached on Apr 29, 2025. View more price dynamics on 1EXAS chart.
See other stocks reaching their highest and lowest prices.
1EXAS stock is 12.31% volatile and has beta coefficient of 0.28. Track EXACT SCIENCES CORP stock price on the chart and check out the list of the most volatile stocks — is EXACT SCIENCES CORP there?
Yes, you can track EXACT SCIENCES CORP financials in yearly and quarterly reports right on TradingView.
EXACT SCIENCES CORP is going to release the next earnings report on Aug 5, 2025. Keep track of upcoming events with our Earnings Calendar.
1EXAS earnings for the last quarter are −0.50 EUR per share, whereas the estimation was −0.35 EUR resulting in a −44.05% surprise. The estimated earnings for the next quarter are −0.11 EUR per share. See more details about EXACT SCIENCES CORP earnings.
EXACT SCIENCES CORP revenue for the last quarter amounts to ‪653.31 M‬ EUR, despite the estimated figure of ‪636.54 M‬ EUR. In the next quarter, revenue is expected to reach ‪683.05 M‬ EUR.
1EXAS net income for the last quarter is ‪−93.56 M‬ EUR, while the quarter before that showed ‪−835.17 M‬ EUR of net income which accounts for 88.80% change. Track more EXACT SCIENCES CORP financial stats to get the full picture.
No, 1EXAS doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of May 4, 2025, the company has ‪7 K‬ employees. See our rating of the largest employees — is EXACT SCIENCES CORP on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. EXACT SCIENCES CORP EBITDA is ‪29.97 M‬ EUR, and current EBITDA margin is 0.84%. See more stats in EXACT SCIENCES CORP financial statements.
Like other stocks, 1EXAS shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade EXACT SCIENCES CORP stock right from TradingView charts — choose your broker and connect to your account.